99% Purity Hot Sale Sorafenib Tosylate for Anti-Tumor Drugs CAS 475207-59-1

Product Description
99% Purity Hot Sale Sorafenib Tosylate for Anti-Tumor Drugs CAS 475207-59-1

  • Model NO.: hangzhou royall
  • Customized: Non-Customized
  • Suitable for: Elderly, Children, Adult
  • Purity: >99%
  • CAS: 475207-59-1
  • Grade Standard: Medicine Grade
  • Shelf Life: 2years
  • Standard: USP Ep Jp etc
  • Appearance: White Powder
  • Transport Package: by Sea, by Air, by Express
  • Origin: Zhejiang, China
  • Powder: Yes
  • Certification: GMP, HSE, ISO 9001, USP, BP
  • State: Solid
  • Product Name: Sorafenib Tosylate
  • Type: Antineoplastic Agents
  • Assay: HPLC 99%
  • Application: Pharma Intermediate
  • Package: 1/5/10/20/25 Kg/Drum/CTN/Bag
  • Trademark: royall
  • Specification: 99%min
  • HS Code: 42356122
Product Description

Jinlan pharm-drug technology Co., Ltd(Hangzhou royall import&export CO.,LTD). is now a leading company in the Chinese pharmaceutical industry, specializing in the development of “New Drugs” (the drugs that previously have not been marketed in China, i.e., New Chemical Entities) as well as the research, development, production and trade of chemical APIs and pharmaceutical intermediates.

Company production base covers an area of 100,000 sq meters. It composed by one pilot plant, 4 Multifunctional composite plants, one GMP Refined drying package workshop High pressure hydrogenation plant. The company is in compliance with GMP guidance, and iscertified with ISO9001:2000 and ISO14001, OHSAS18001.

We produce lots of API and relative pharmaceutical intermediates Such as Antineoplastic medicines (Lapatinib,Sorafenib, Sunitinib, Dasatinib, Erlotinib, Ceritinib, Nilotinib, Afatinib, etc.)& other API and intermediate: Ibrutinib, Crizotinib, Tofacitinib,  Cinacalcet Hydrochloride, etc.

Author: chemicals

Here is chemical sourse

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s